Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...

Factors related to sex and gender can affect therapy outcomes and should not be overlooked in clinical practice or research.

An attempt by Merck & Co. to unlock the microsatellite stable (MSS) metastatic colorectal cancer market has ended in failure.

A new report from the American Association for Cancer Research shows cancer is affecting more and more young adults.

Symptoms of anaemia include fatigue, cold hands and feet, hair loss, brittle nails, cognitive issues like brain fog, ...

Anbogen, a clinical-stage biotech company, today announced a drug supply collaboration to evaluate the combination of Anbogen's HDAC inhibitor, ABT-301, with BeiGene's anti-PD-1 antibody tislelizumab, ...

Many people are simply unaware of the existence of the FIT test or underestimate its importance in colorectal cancer ...

After facing colorectal cancer for nearly eight years, Mandy Wilk got a double-lung transplant in June at Northwestern. She ...

Pseudopolyps ocurr due to the inflammation related to Crohn's disease or ulcerative colitis. Learn what pseudopolyps on ...

A Bloomington educator who battled stage 4 colorectal cancer for nearly a decade and faced a grim prognosis is now in ...

Merck follows in the footsteps of Bristol Myers Squibb, which in December 2023 also failed to secure a late-stage victory for ...

Merck & Co Inc (NYSE:MRK) released topline data from the KEYFORM-007 Phase 3 study of the fixed-dose combination of ...